Fellowship ​

The Australian Academy of Health and Medical Sciences elects the best and brightest minds in the field of medical and health sciences as Fellows.

Fellows are elected in recognition of their outstanding achievements and exceptional contributions to the sector. The Fellowship are acknowledged for their clinical, non-clinical, leadership, industry and research contributions.

Find Fellows of the AAHMS

To find Fellows of our Academy either use the search form below or download the full list of current Fellows here.






Head, School of Clinical Sciences
Monash University

Professor Peter Ebeling’s national and international recognition for excellence in health and medical science is demonstrated by key leadership roles at the highest level, including as first non-North American President of the American Society of Bone and Mineral Research, Past-president of the Endocrine Society of Australia and Australian and New Zealand Bone and Mineral Society, and Board Member of the International Osteoporosis Foundation. Professor Ebeling mentors PhD students and endocrinology trainees and chairs Healthy Bones Australia, through which he has raised public understanding of bone health.

Professor Ebeling’s significant, sustained and ongoing contributions to advance health and medical science have led to changes in clinical practice and health policy.

Director, Institute of Clinical Pathology and Medical Research (ICPMR); Director of Public Health Pathology, NSW Health Pathology
Westmead Hospital

Professor Dominic Dwyer is a clinical virologist and infectious diseases physician, trained in Sydney with doctoral research undertaken at the Institut Pasteur, Paris. He is the NSW Director of Public Health Pathology, and Director of the Institute Of Clinical Pathology and Medical Research (ICPMR) at Westmead. He is an expert in emerging infections, an investigator in many antiviral drug/vaccine trials, and has published over 480 papers. He has worked with the World Health Organization, including as a member of the WHO Study of the Origins of SARS-CoV-2 (Wuhan 2021).

Professor Dwyer has a prominent media presence, and has worked on various international and national committees and advisory boards.

Director of Research, Institute of Molecular Biosciences
The University of Queensland

Professor Denise Doolan is a Professorial Research Fellow and Acting Director of the Australian Institute of Tropical Health and Medicine at James Cook University. She is a molecular immunologist with multidisciplinary research focuses on developing therapeutics and diagnostics for infectious diseases that impact global public health.

Professor Doolan’s research has provided critical insights into multiple facets of malaria immunology, vaccine antigens, and vaccine and diagnostic platform development, extending to the more general fields of immunology, vaccinology and public health. Professor Doolan champions health and medical research and capacity development for populations in the tropics, including regional Australia.

Professor of Medicine; Head, Eastern Health Clinical School
Monash University

Professor Ian Davis is a medical oncologist with over 30 years’ experience and primary clinical and research focus in genitourinary cancers. He founded and chairs the ANZUP (Australian and New Zealand Urogenital and Prostate) Cancer Trials Group and is the global co-chair of international ANZUP ENZAMET trial. This trial demonstrated improved survival with enzalutamide for metastatic hormone-sensitive prostate cancer and has led to regulatory approval in US, Europe, Japan, and Australia, leading to multiple awards, including the 2020 Trial of the Year.

Through ANZUP, Professor Davis has established a global genitourinary cancer clinical trials network and mentored many senior clinician-researchers.

Group Leader, Cancer Immunotherapy Laboratory
Peter MacCallum Cancer Centre

Professor Phillip Darcy is an NHMRC Principal Research Fellow and Group Leader at the Peter MacCallum Cancer Centre. His work has been pivotal in developing novel T cell-based immunotherapy approaches for cancer patients. In particular, his studies involving the development of technology using gene‐modified T cells expressing chimeric antigen receptors (CARs) in preclinical models has led to licensing of an international patent to industry partners and underpins five FDA/TGA‐approved therapies for CD19+ blood cancers.

Professor Darcy’s work has also been integral in the first CAR T cell trial undertaken in Australia.

Head of Paediatrics
The University of Adelaide

Professor Jenny Couper is a practising clinician and researcher who leads innovations for children at-risk or with type 1 diabetes. Her research is in the prevention of type 1 diabetes and the prevention of cardiovascular complications. She heads the first global investigation of the early life origins of type 1 diabetes and co-leads prevention trials. Through her work, she has found ways to detect cardiovascular disease early in children with type 1 diabetes and shown the benefits of exercise, diet and medication.

Professor Couper trains paediatric endocrinologists, writes international guidelines and facilitates international training on the International Society of Pediatrics and Adolescent Diabetes Advisory Council.

Professor In Biostatistics
The University of Melbourne

Professor Leonid Churilov is a clinical biostatistician who led complex and comprehensive design and analysis of acute and recovery stroke trials that resulted in global changes in clinical practice, and are internationally recognized through multiple publications in the highest impact medical journals including NEJM, The Lancet and JAMA.

Professor Churilov led the development, and wide adoption by the Australian stroke clinical community, of novel clinical trial designs, original analytical approaches and outcome measurements from “bench-to-bedside”. His decision-modelling effort provided analytical underpinnings for acute stroke processes of care adopted both nationally and internationally, including the activities of the first Australian stroke ambulance.

Senior Research Fellow and Group Leader
Murdoch Children’s Research Institute

Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He is Education Officer for the World Society of Paediatric Infectious Diseases.

Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection and inflammation, particularly in relation to the development of cardiometabolic disease risk. He is an internationally-recognised clinical and scientific leader in Kawasaki disease and has made major scientific, clinical and policy contributions to the Australian response to the COVID-19 pandemic, particularly the hyperinflammatory post-infectious syndrome in children.

Emeritus Professor, Health Futures Institute
Murdoch University

Professor Susan Fletcher is Senior Principal Research Fellow at Murdoch University and in 2020 was appointed Chief Scientific Officer (fractional position) at ASX-listed biotech PYC Therapeutics. Alongside her collaborator Professor Steve Wilton, she pioneered ‘molecular drugs’ to treat inherited disease by altering the gene message to overcome disease-causing mutations. In 2016, 2019 and 2021, the drugs ExonDys51, Vyondys53 and Amondys45 (respectively) from their laboratory became the first and only drugs to have altered the natural history of the fatal inherited muscle disease, Duchenne muscular dystrophy.

As lead investigator, Professor Fletcher is working with PYC Therapeutics to take VP-001 through clinical development to treat retinitis pigmentosa 11.

Honorary Professor, Faculty of Medicine
The University of Sydney

Professor Bruce Robinson has received national and international recognition through awards and invitations to speak and write on endocrine tumours. He has forged links with countries in SE Asia including Vietnam, Cambodia, Myanmar and China and has assisted in training hundreds of health professionals from these countries. He has reformed curricula locally and is working to assist this process in Vietnam and Myanmar. He has mentored many students in scientific method and supported their career development. He is an advocate for patient groups with endocrine disease including thyroid and endocrine tumours.

About Fellowship with AAHMS

Our Fellows sit at the heart of everything we do. They represent Australia’s leading minds in health and medical sciences, having been recognised for their clinical, non-clinical, leadership, industry and research contributions.

To be considered for election to the Academy’s Fellowship, a candidate must show exceptional professional achievement in a field related to health and/or medicine.

Fellows contribute to the projects and activities of the Academy and must be willing to be active participants.

Successful Fellowship candidates will have shown:

  • Outstanding leadership in their field.
  • Significant and ongoing involvement with issues of health care, prevention of disease, education, research, and health services policy and delivery.

Candidates for Fellowship should meet the following criteria:

  • National and International recognition for excellence in health and medical science
  • Significant, sustained and ongoing contributions to advance health and medical science in Australia (relative to opportunity)
  • Contribution to the profession through leadership and mentorship
  • Raised public understanding and promoting health and medical science in the broader community

Download criteria for Fellowship

Each year, current Fellows of the Academy are invited to nominate up to four new candidates who meet the criteria and fulfil the required expectations.

To ensure the Academy has a representative and diverse membership, Fellows nominating two new candidates are asked to include only a maximum of one man, and Fellows nominating four new candidates are asked to include only a maximum of two men.

How to make a nomination

Fellows wishing to nominate a candidate for Fellowship should contact the secretariat to confirm candidate eligibility and receive and instructions on how to submit the completed nomination documentation online. 

Fellows wishing to nominate a candidate for a Corresponding Fellowship should contact the secretariat for more information.

Secretariat contact details
Email: [email protected]

Phone: 07 3102 7220

Nomination guidelines for ordinary Fellowship

October 2023
Newly elected Fellows of 2023 are inducted at the Annual Meeting.

18 September 2023- 30 November 2023
Nominations are invited from existing Fellows until the closing date of 30 November.

December 2023
Nominations allocated to Selection Committees.

January – April 2024
Referees’ reports sought.

Early May 2024
Selection Committees meet to consider nominations and provide final recommendations to the Council.

Early-to-mid-July 2024
Council meets to finalise recommendations.

Late July 2024
Full Fellowship invited to comment on recommended new fellows.

August 2024
Election results are shared with proposers and candidates (under embargo).

October 2024
Newly elected Fellows of 2024 inducted at the Annual Meeting.

Keep up to date with the latest news

By providing your email address, you consent to it being added to our mailing list.